{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:51:36Z","timestamp":1783666296617,"version":"3.55.0"},"reference-count":239,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Progressive supranuclear palsy is a sporadic neurodegenerative 4-repeat tauopathy associated with significant morbidity. Heterogeneity of symptom expression among this group is increasingly recognized, reflecting variable tau spread and neurodegeneration. Clinical manifestations consist of debilitating and rapidly progressive motor, oculomotor, speech, cognitive and affective impairments. Core pathological changes are noted with a predominance in the midbrain and basal ganglia; however, spread to the more caudal brainstem and cerebellar regions is reported at various stages. Accordingly, whilst midbrain atrophy is the best recognized supportive imaging finding, quantitative neuroimaging studies using MRI and PET approaches have revealed a wider profile of brain abnormalities in cohorts of individuals with progressive supranuclear palsy. This expanded neurobiological scope of disease may account for individual heterogeneity and may highlight additional biological markers that are relevant to diagnosing and tracking the illness. Additionally, there is increasing understanding of the diverse cognitive, affective and speech functions of the cerebellum, which may be implicated in progressive supranuclear palsy beyond current recognition. In this review, we undertake a systematic literature search and summary of in vivo structural and functional neuroimaging findings in the brainstem and cerebellum in progressive supranuclear palsy to date. Novel and multimodal imaging techniques have emerged over recent years, which reveal several infratentorial alterations beyond midbrain atrophy in progressive supranuclear palsy. Most saliently, there is evidence for volume loss and microstructural damage in the pons, middle cerebellar peduncles and cerebellar cortex and deep nuclei, reported alongside recognized midbrain and superior cerebellar peduncle changes. Whilst the literature supporting the presence of these features is not unanimous, the evidence base is compelling, including correlations with disease progression, severity or variant differences. A smaller number of studies report on abnormalities in MRI measures of iron deposition, neuromelanin, viscoelasticity and the glymphatic system involving the infratentorial regions. Molecular imaging studies have also shown increased uptake of tau tracer in the midbrain and cerebellar dentate nucleus, although concern remains regarding possible off-target binding. Imaging of other molecular targets has been sparse, but reports of neurotransmitter, inflammatory and synaptic density alterations in cerebellar and brainstem regions are available. Taken together, there is an established evidence base of in vivo imaging alterations in the brainstem and cerebellum which highlights that midbrain atrophy is often accompanied by other infratentorial alterations in people with progressive supranuclear palsy. Further research examining the contribution of these features to clinical morbidity and inter-individual variability in symptom expression is warranted.<\/jats:p>","DOI":"10.1093\/braincomms\/fcaf051","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T04:22:24Z","timestamp":1738642944000},"source":"Crossref","is-referenced-by-count":12,"title":["Brainstem and cerebellar radiological findings in progressive supranuclear palsy"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4274-2785","authenticated-orcid":false,"given":"Chloe","family":"Spiegel","sequence":"first","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University , Melbourne 3004 ,","place":["Australia"]},{"name":"Department of Neurology, Alfred Health , Melbourne 3004 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8430-4824","authenticated-orcid":false,"given":"Cassandra","family":"Marotta","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University , Melbourne 3004 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Bertram","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University , Melbourne 3004 ,","place":["Australia"]},{"name":"Department of Neurology, Alfred Health , Melbourne 3004 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1182-0907","authenticated-orcid":false,"given":"Lucy","family":"Vivash","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University , Melbourne 3004 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H","family":"Harding","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University , Melbourne 3004 ,","place":["Australia"]},{"name":"QIMR Berghofer Medical Research Institute , Brisbane 4006 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"issue":"6","key":"2025021510464230500_fcaf051-B1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria: MDS clinical diagnostic criteria for PSP","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"issue":"5","key":"2025021510464230500_fcaf051-B2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/practneurol-2020-002794","article-title":"Progressive supranuclear palsy: Diagnosis and management","volume":"21","author":"Rowe","year":"2021","journal-title":"Pract Neurol"},{"issue":"8","key":"2025021510464230500_fcaf051-B3","doi-asserted-by":"crossref","first-page":"e16320","DOI":"10.1111\/ene.16320","article-title":"Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy","volume":"31","author":"Badihian","year":"2024","journal-title":"Eur J Neurol"},{"issue":"7","key":"2025021510464230500_fcaf051-B4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/mds.27038","article-title":"Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? : Neuroimaging biomarkers for diagnosis in PSP","volume":"32","author":"Whitwell","year":"2017","journal-title":"Mov Disord"},{"issue":"4","key":"2025021510464230500_fcaf051-B5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/mds.27621","article-title":"Refining initial diagnosis of Parkinson\u2019s disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study","volume":"34","author":"Morelli","year":"2019","journal-title":"Mov Disord"},{"issue":"1","key":"2025021510464230500_fcaf051-B6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00005072-199601000-00010","article-title":"Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders","volume":"55","author":"Litvan","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"2025021510464230500_fcaf051-B7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","article-title":"Distribution patterns of tau pathology in progressive supranuclear palsy","volume":"140","author":"Kovacs","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"9","key":"2025021510464230500_fcaf051-B8","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/mds.22583","article-title":"Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study","volume":"24","author":"Kanazawa","year":"2009","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"3","key":"2025021510464230500_fcaf051-B9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0317167100014232","article-title":"The role of the cerebellum in the pathophysiology of Parkinson\u2019s disease","volume":"40","author":"Lewis","year":"2013","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"issue":"8","key":"2025021510464230500_fcaf051-B10","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.neurobiolaging.2013.02.013","article-title":"Different patterns of gray matter atrophy in early- and late-onset Alzheimer\u2019s disease","volume":"34","author":"M\u00f6ller","year":"2013","journal-title":"Neurobiol Aging"},{"issue":"2-3","key":"2025021510464230500_fcaf051-B11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.eplepsyres.2008.01.006","article-title":"Subcortical and cerebellar atrophy in mesial temporal lobe epilepsy revealed by automatic segmentation","volume":"79","author":"McDonald","year":"2008","journal-title":"Epilepsy Res"},{"key":"2025021510464230500_fcaf051-B12","doi-asserted-by":"crossref","first-page":"957997","DOI":"10.3389\/fnagi.2022.957997","article-title":"Abnormal cortical atrophy and functional connectivity are associated with depression in Parkinson\u2019s disease","volume":"14","author":"Yin","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"15","key":"2025021510464230500_fcaf051-B13","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1002\/hbm.25606","article-title":"Topologically convergent and divergent morphological gray matter networks in early-stage Parkinson\u2019s disease with and without mild cognitive impairment","volume":"42","author":"Suo","year":"2021","journal-title":"Hum Brain Mapp"},{"issue":"9","key":"2025021510464230500_fcaf051-B14","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/jnnp-2017-315607","article-title":"Cerebellar atrophy in neurodegeneration\u2014A meta-analysis","volume":"88","author":"Gellersen","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"2025021510464230500_fcaf051-B15","first-page":"849","article-title":"CT in progressive supranuclear palsy","volume":"8","author":"Ambrosetto","year":"1987","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"2025021510464230500_fcaf051-B16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0404.2006.00767.x","article-title":"Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging","volume":"116","author":"Cosottini","year":"2007","journal-title":"Acta Neurol Scand"},{"issue":"14","key":"2025021510464230500_fcaf051-B17","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/mds.24968","article-title":"Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy","volume":"27","author":"Massey","year":"2012","journal-title":"Mov Disord"},{"key":"2025021510464230500_fcaf051-B18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.nicl.2016.05.016","article-title":"Accuracy of MR markers for differentiating progressive supranuclear palsy from Parkinson\u2019s disease","volume":"11","author":"Zanigni","year":"2016","journal-title":"NeuroImage Clin"},{"issue":"3","key":"2025021510464230500_fcaf051-B19","doi-asserted-by":"crossref","first-page":"e200157","DOI":"10.1212\/CPJ.0000000000200157","article-title":"Structural MRI ratios fail to distinguish progressive supranuclear palsy from Parkinson disease in individual patients","volume":"13","author":"Dewey","year":"2023","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"2025021510464230500_fcaf051-B20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/jnnp.62.3.239","article-title":"Proton magnetic resonance spectroscopy in Parkinson\u2019s disease and progressive supranuclear palsy","volume":"62","author":"Federico","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"2025021510464230500_fcaf051-B21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1468-1331.2010.03010.x","article-title":"Quantitative magnetic resonance spectroscopic imaging in Parkinson\u2019s disease, progressive supranuclear palsy and multiple system atrophy","volume":"17","author":"Guevara","year":"2010","journal-title":"Eur J Neurol"},{"issue":"9","key":"2025021510464230500_fcaf051-B22","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/brain\/120.9.1541","article-title":"Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson\u2019s disease and corticobasal degeneration","volume":"120","author":"Tedeschi","year":"1997","journal-title":"Brain J Neurol"},{"issue":"3","key":"2025021510464230500_fcaf051-B23","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1097\/RLU.0000000000000315","article-title":"Brain 18F-FDG PET imaging in the differential diagnosis of parkinsonism","volume":"39","author":"Akdemir","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"1-2","key":"2025021510464230500_fcaf051-B24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-510X(02)00102-8","article-title":"Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration","volume":"199","author":"Hosaka","year":"2002","journal-title":"J Neurol Sci"},{"issue":"2","key":"2025021510464230500_fcaf051-B25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-0404.2004.00293.x","article-title":"Midbrain hypometabolism as early diagnostic sign for progressive supranuclear palsy","volume":"110","author":"Mishina","year":"2004","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"2025021510464230500_fcaf051-B26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.mnm.0000202858.45522.df","article-title":"123I-FP-CIT in progressive supranuclear palsy and in Parkinson\u2019s disease: A SPECT semiquantitative study","volume":"27","author":"Filippi","year":"2006","journal-title":"Nucl Med Commun"},{"issue":"6","key":"2025021510464230500_fcaf051-B27","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2214\/AJR.19.22436","article-title":"Diagnostic performance of (123)I-FPCIT SPECT specific binding ratio in progressive supranuclear palsy: Use of core clinical features and MRI for comparison","volume":"215","author":"Sakamoto","year":"2020","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"2025021510464230500_fcaf051-B28","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/mds.28992","article-title":"Development and validation of automated magnetic resonance parkinsonism index 2.0 to distinguish progressive supranuclear palsy-parkinsonism from Parkinson\u2019s disease","volume":"37","author":"Quattrone","year":"2022","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"2025021510464230500_fcaf051-B29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.parkreldis.2020.11.019","article-title":"Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism","volume":"82","author":"Heim","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"2025021510464230500_fcaf051-B30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.parkreldis.2019.08.007","article-title":"Diagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson\u2019s disease","volume":"66","author":"Zhang","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"2025021510464230500_fcaf051-B31","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00415-020-10230-w","article-title":"Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy","volume":"268","author":"Choi","year":"2021","journal-title":"J Neurol"},{"issue":"1","key":"2025021510464230500_fcaf051-B32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/mds.27877","article-title":"Multimodal magnetic resonance imaging quantification of brain changes in progressive supranuclear palsy","volume":"35","author":"Pyatigorskaya","year":"2020","journal-title":"Mov Disord"},{"key":"2025021510464230500_fcaf051-B33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.parkreldis.2019.07.001","article-title":"Multimodal neuroimaging relationships in progressive supranuclear palsy","volume":"66","author":"Sintini","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"2025021510464230500_fcaf051-B34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/mds.26470","article-title":"Neuroimaging correlates of blinking abnormalities in patients with progressive supranuclear palsy","volume":"31","author":"Bologna","year":"2016","journal-title":"Mov Disord"},{"issue":"10","key":"2025021510464230500_fcaf051-B35","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1007\/s00415-016-8224-y","article-title":"MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome","volume":"263","author":"Upadhyay","year":"2016","journal-title":"J Neurol"},{"issue":"8","key":"2025021510464230500_fcaf051-B36","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s00415-015-7779-3","article-title":"Neuroimaging evidence of gray and white matter damage and clinical correlates in progressive supranuclear palsy","volume":"262","author":"Piattella","year":"2015","journal-title":"J Neurol"},{"issue":"3","key":"2025021510464230500_fcaf051-B37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.parkreldis.2010.12.010","article-title":"Patterns of brain atrophy in Parkinson\u2019s disease, progressive supranuclear palsy and multiple system atrophy","volume":"17","author":"Messina","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"2025021510464230500_fcaf051-B38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1531-8249(199901)45:1<65::AID-ART12>3.0.CO;2-1","article-title":"Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson\u2019s syndrome from multiple system atrophy and progressive supranuclear palsy","volume":"45","author":"Schulz","year":"1999","journal-title":"Ann Neurol"},{"issue":"22","key":"2025021510464230500_fcaf051-B39","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1212\/01.wnl.0000335941.68602.39","article-title":"Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy","volume":"71","author":"Borroni","year":"2008","journal-title":"Neurology"},{"key":"2025021510464230500_fcaf051-B40","doi-asserted-by":"crossref","first-page":"101722","DOI":"10.1016\/j.nicl.2019.101722","article-title":"Atrophy in midbrain & cerebral\/cerebellar pedunculi is characteristic for progressive supranuclear palsy\u2014A double-validation whole-brain meta-analysis","volume":"22","author":"Albrecht","year":"2019","journal-title":"NeuroImage Clin"},{"issue":"6","key":"2025021510464230500_fcaf051-B41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/mdc3.12796","article-title":"An evaluation of the progressive supranuclear palsy speech\/language variant","volume":"6","author":"Whitwell","year":"2019","journal-title":"Mov Disord Clin Pract"},{"issue":"MAR","key":"2025021510464230500_fcaf051-B42","first-page":"100","article-title":"Disease-specific regions outperform whole-brain approaches in identifying progressive supranuclear palsy: A multicentric MRI study","volume":"11","author":"Mueller","year":"2017","journal-title":"Front Neurosci"},{"issue":"1 FEB","key":"2025021510464230500_fcaf051-B43","first-page":"63","article-title":"Voxelwise meta-analysis of gray matter anomalies in progressive supranuclear palsy and Parkinson\u2019s disease using anatomic likelihood estimation","volume":"8","author":"Shao","year":"2014","journal-title":"Front Hum Neurosci"},{"issue":"4","key":"2025021510464230500_fcaf051-B44","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/brain\/awl021","article-title":"Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: Rates and regions of atrophy","volume":"129","author":"Paviour","year":"2006","journal-title":"Brain"},{"issue":"19","key":"2025021510464230500_fcaf051-B45","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1212\/WNL.0000000000003305","article-title":"Progression of brain atrophy in PSP and CBS over 6 months and 1 year","volume":"87","author":"Dutt","year":"2016","journal-title":"Neurology"},{"key":"2025021510464230500_fcaf051-B46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.parkreldis.2018.02.004","article-title":"Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy","volume":"49","author":"Seki","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"2025021510464230500_fcaf051-B47","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1460-9568.2010.07304.x","article-title":"The in vivo distribution of brain tissue loss in Richardson\u2019s syndrome and PSP-parkinsonism: A VBM-DARTEL study","volume":"32","author":"Agosta","year":"2010","journal-title":"Eur J Neurosci"},{"key":"2025021510464230500_fcaf051-B48","doi-asserted-by":"crossref","first-page":"102152","DOI":"10.1016\/j.nicl.2019.102152","article-title":"Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants","volume":"25","author":"Whitwell","year":"2020","journal-title":"NeuroImage Clin"},{"issue":"8","key":"2025021510464230500_fcaf051-B49","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1093\/brain\/awq162","article-title":"Magnetic resonance imaging lesion pattern in guadeloupean parkinsonism is distinct from progressive supranuclear palsy","volume":"133","author":"Lehericy","year":"2010","journal-title":"Brain"},{"issue":"7","key":"2025021510464230500_fcaf051-B50","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/jnnp-2017-317443","article-title":"Tracking brain damage in progressive supranuclear palsy: A longitudinal MRI study","volume":"89","author":"Agosta","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025021510464230500_fcaf051-B51","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1007\/s00330-023-09435-0","article-title":"Midbrain and pons MRI shape analysis and its clinical and CSF correlates in degenerative parkinsonisms: A pilot study","volume":"33","author":"Painous","year":"2023","journal-title":"Eur Radiol"},{"issue":"2","key":"2025021510464230500_fcaf051-B52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/ene.15603","article-title":"The many faces of globular glial tauopathy: A clinical and imaging study","volume":"30","author":"Buciuc","year":"2023","journal-title":"Eur J Neurol"},{"issue":"2","key":"2025021510464230500_fcaf051-B53","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/WNO.0000000000001393","article-title":"Clinical correlation between vertical gaze palsy and midbrain volume in progressive supranuclear palsy","volume":"42","author":"Buch","year":"2022","journal-title":"J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc"},{"issue":"2","key":"2025021510464230500_fcaf051-B54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10072-017-3212-2","article-title":"Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy","volume":"39","author":"Constantinides","year":"2018","journal-title":"Neurol Sci"},{"issue":"13","key":"2025021510464230500_fcaf051-B55","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/WNL.0000000000002518","article-title":"Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism","volume":"86","author":"Scherfler","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"2025021510464230500_fcaf051-B56","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/mds.26715","article-title":"Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification","volume":"31","author":"Huppertz","year":"2016","journal-title":"Mov Disord"},{"issue":"1-2","key":"2025021510464230500_fcaf051-B57","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jns.2015.11.007","article-title":"Quantitative assessment of cerebral gray matter density change in progressive supranuclear palsy using voxel based morphometry analysis and cerebral MR T1-weighted FLAIR imaging","volume":"359","author":"Wang","year":"2015","journal-title":"J Neurol Sci"},{"issue":"12","key":"2025021510464230500_fcaf051-B58","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1152\/jn.00062.2014","article-title":"The binaural masking level difference: Cortical correlates persist despite severe brain stem atrophy in progressive supranuclear palsy","volume":"112","author":"Hughes","year":"2014","journal-title":"J Neurophysiol"},{"issue":"8","key":"2025021510464230500_fcaf051-B59","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/mds.25437","article-title":"Modeling trajectories of regional volume loss in progressive supranuclear palsy","volume":"28","author":"Josephs","year":"2013","journal-title":"Mov Disord"},{"issue":"11","key":"2025021510464230500_fcaf051-B60","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1468-1331.2012.03726.x","article-title":"Neuroanatomical correlates of the progressive supranuclear palsy corticobasal syndrome hybrid","volume":"19","author":"Josephs","year":"2012","journal-title":"Eur J Neurol"},{"issue":"7","key":"2025021510464230500_fcaf051-B61","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00234-011-0983-7","article-title":"In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS","volume":"54","author":"Saini","year":"2012","journal-title":"Neuroradiology"},{"issue":"2","key":"2025021510464230500_fcaf051-B62","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2006.09.019","article-title":"Voxel-based morphometry in autopsy proven PSP and CBD","volume":"29","author":"Josephs","year":"2008","journal-title":"Neurobiol Aging"},{"issue":"7","key":"2025021510464230500_fcaf051-B63","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/mds.20877","article-title":"Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations","volume":"21","author":"Paviour","year":"2006","journal-title":"Mov Disord"},{"issue":"1-2","key":"2025021510464230500_fcaf051-B64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(03)00014-5","article-title":"Study of the rostral midbrain atrophy in progressive supranuclear palsy","volume":"210","author":"Kato","year":"2003","journal-title":"J Neurol Sci"},{"issue":"2","key":"2025021510464230500_fcaf051-B65","first-page":"246","article-title":"Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy","volume":"75","author":"Brenneis","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"2025021510464230500_fcaf051-B66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00702-002-0785-5","article-title":"Routine MRI for the differential diagnosis of Parkinson\u2019s disease, MSA, PSP, and CBD","volume":"110","author":"Yekhlef","year":"2003","journal-title":"J Neural Transm"},{"issue":"12","key":"2025021510464230500_fcaf051-B67","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s007020070006","article-title":"Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy","volume":"107","author":"Asato","year":"2000","journal-title":"J Neural Transm"},{"issue":"9513583","key":"2025021510464230500_fcaf051-B68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.parkreldis.2020.08.004","article-title":"Automated brainstem volumetry can aid in the diagnostics of parkinsonian disorders","volume":"79","author":"Sjostrom","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"2025021510464230500_fcaf051-B69","doi-asserted-by":"crossref","first-page":"120514","DOI":"10.1016\/j.jns.2022.120514","article-title":"Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsy","volume":"444","author":"Matsuoka","year":"2023","journal-title":"J Neurol Sci"},{"key":"2025021510464230500_fcaf051-B70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.parkreldis.2020.02.007","article-title":"Diagnostic potential of automated tractography in progressive supranuclear palsy variants","volume":"72","author":"Potrusil","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"2025021510464230500_fcaf051-B71","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.02.022","article-title":"Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study","volume":"63","author":"Caligiuri","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"2025021510464230500_fcaf051-B72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/brb3.329","article-title":"Patterns of gray matter atrophy in atypical parkinsonism syndromes: A VBM meta-analysis","volume":"5","author":"Yu","year":"2015","journal-title":"Brain Behav"},{"issue":"11","key":"2025021510464230500_fcaf051-B73","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/hbm.21161","article-title":"Individual voxel-based subtype prediction can differentiate progressive supranuclear palsy from idiopathic Parkinson syndrome and healthy controls","volume":"32","author":"Focke","year":"2011","journal-title":"Hum Brain Mapp"},{"issue":"10","key":"2025021510464230500_fcaf051-B74","first-page":"1709","article-title":"Evaluation of cortical atrophy between progressive supranuclear palsy and corticobasal degeneration by hemispheric surface display of MR images","volume":"25","author":"Taki","year":"2004","journal-title":"AJNR Am J Neuroradiol."},{"issue":"12","key":"2025021510464230500_fcaf051-B75","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1212\/01.WNL.0000165960.04422.D0","article-title":"New and reliable MRI diagnosis for progressive supranuclear palsy","volume":"64","author":"Oba","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"2025021510464230500_fcaf051-B76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3988\/jcn.2020.16.1.37","article-title":"A cortical substrate for square-wave jerks in progressive supranuclear palsy","volume":"16","author":"Anagnostou","year":"2020","journal-title":"J Clin Neurol Korea"},{"issue":"9513583","key":"2025021510464230500_fcaf051-B77","doi-asserted-by":"crossref","first-page":"105287","DOI":"10.1016\/j.parkreldis.2023.105287","article-title":"Comparison of mean diffusivity, R2* relaxation rate and morphometric biomarkers for the clinical differentiation of parkinsonism","volume":"108","author":"Chougar","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"2025021510464230500_fcaf051-B78","doi-asserted-by":"crossref","first-page":"e4795","DOI":"10.1002\/nbm.4795","article-title":"Automated volumetric determination of high R(2) (*) regions in substantia nigra: A feasibility study of quantifying substantia nigra atrophy in progressive supranuclear palsy","volume":"35","author":"Tessema","year":"2022","journal-title":"NMR Biomed"},{"issue":"4","key":"2025021510464230500_fcaf051-B79","first-page":"666","article-title":"The role of width of pars compacta of substantia nigra and the midbrain area in patients with Parkinson\u2019s disease and progressive supranuclear palsy with healthy aged individuals","volume":"42","author":"Hosapatna","year":"2022","journal-title":"Biomed India"},{"issue":"9","key":"2025021510464230500_fcaf051-B80","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/mds.27365","article-title":"Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson\u2019s disease","volume":"33","author":"Taniguchi","year":"2018","journal-title":"Mov Disord"},{"issue":"16","key":"2025021510464230500_fcaf051-B81","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2169\/internalmedicine.50.5101","article-title":"Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD","volume":"50","author":"Kashihara","year":"2011","journal-title":"Intern Med"},{"key":"2025021510464230500_fcaf051-B82","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.parkreldis.2021.05.002","article-title":"Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia","volume":"87","author":"Matsuura","year":"2021","journal-title":"Park Relat Disord"},{"issue":"3","key":"2025021510464230500_fcaf051-B83","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1468-1331.2012.03884.x","article-title":"Subcortical structures in progressive supranuclear palsy: Vertex-based analysis","volume":"20","author":"Saini","year":"2013","journal-title":"Eur J Neurol"},{"issue":"11","key":"2025021510464230500_fcaf051-B84","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1212\/WNL.39.11.1524","article-title":"Magnetic resonance imaging in Parkinson\u2019s disease and parkinsonian syndromes","volume":"39","author":"Stern","year":"1989","journal-title":"Neurology"},{"issue":"6","key":"2025021510464230500_fcaf051-B85","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1007\/s00415-021-10936-5","article-title":"Peripapillary retinal nerve fiber layer thinning in patients with progressive supranuclear palsy","volume":"269","author":"Woo","year":"2022","journal-title":"J Neurol"},{"issue":"4","key":"2025021510464230500_fcaf051-B86","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.parkreldis.2010.01.002","article-title":"Sleep disturbances and brain MRI morphometry in Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy\u2014A comparative study","volume":"16","author":"Gama","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"2025021510464230500_fcaf051-B87","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1148\/radiol.12120364","article-title":"Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease","volume":"267","author":"Nicoletti","year":"2013","journal-title":"Radiology"},{"key":"2025021510464230500_fcaf051-B88","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.nicl.2018.09.028","article-title":"Widespread diffusion changes differentiate Parkinson\u2019s disease and progressive supranuclear palsy","volume":"20","author":"Talai","year":"2018","journal-title":"NeuroImage Clin"},{"issue":"5","key":"2025021510464230500_fcaf051-B89","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/WNR.0000000000000341","article-title":"Differentiation among parkinsonisms using quantitative diffusion kurtosis imaging","volume":"26","author":"Ito","year":"2015","journal-title":"NeuroReport"},{"issue":"8","key":"2025021510464230500_fcaf051-B90","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00234-017-1870-7","article-title":"Differential diagnosis of parkinsonism by a combined use of diffusion kurtosis imaging and quantitative susceptibility mapping","volume":"59","author":"Ito","year":"2017","journal-title":"Neuroradiology"},{"issue":"9","key":"2025021510464230500_fcaf051-B91","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00415-017-8579-8","article-title":"Regional microstructural damage and patterns of eye movement impairment: A DTI and video-oculography study in neurodegenerative parkinsonian syndromes","volume":"264","author":"Gorges","year":"2017","journal-title":"J Neurol"},{"issue":"7","key":"2025021510464230500_fcaf051-B92","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00234-015-1515-7","article-title":"Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism","volume":"57","author":"Meijer","year":"2015","journal-title":"Neuroradiology"},{"issue":"11","key":"2025021510464230500_fcaf051-B93","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00234-015-1563-z","article-title":"Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy","volume":"57","author":"Surova","year":"2015","journal-title":"Neuroradiology"},{"issue":"6","key":"2025021510464230500_fcaf051-B94","doi-asserted-by":"crossref","first-page":"e0157218","DOI":"10.1371\/journal.pone.0157218","article-title":"Progression of microstructural degeneration in progressive supranuclear palsy and corticobasal syndrome: A longitudinal diffusion tensor imaging study","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"2025021510464230500_fcaf051-B95","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parkreldis.2014.01.023","article-title":"Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes","volume":"20","author":"Whitwell","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"2025021510464230500_fcaf051-B96","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00234-012-1009-9","article-title":"Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson\u2019s disease: Evaluation by 3.0-T MR imaging","volume":"54","author":"Tsukamoto","year":"2012","journal-title":"Neuroradiology"},{"issue":"1","key":"2025021510464230500_fcaf051-B97","doi-asserted-by":"crossref","first-page":"e85194","DOI":"10.1371\/journal.pone.0085194","article-title":"Spin-lattice distribution MRI maps nigral pathology in progressive supranuclear palsy (PSP) during life: A pilot study","volume":"9","author":"Hutchinson","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"2025021510464230500_fcaf051-B98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0004-282X2009000100002","article-title":"Neuroimaging in parkinsonism: A study with magnetic resonance and spectroscopy as tools in the differential diagnosis","volume":"67","author":"Vasconcellos","year":"2009","journal-title":"Arq Neuropsiquiatr"},{"issue":"10","key":"2025021510464230500_fcaf051-B99","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/mds.27100","article-title":"Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study","volume":"32","author":"Ofori","year":"2017","journal-title":"Mov Disord"},{"issue":"17","key":"2025021510464230500_fcaf051-B100","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1002\/hbm.24760","article-title":"Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in parkinsonism","volume":"40","author":"Mitchell","year":"2019","journal-title":"Hum Brain Mapp"},{"issue":"Pt 2","key":"2025021510464230500_fcaf051-B101","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/awv361","article-title":"Free-water imaging in Parkinson\u2019s disease and atypical parkinsonism","volume":"139","author":"Planetta","year":"2016","journal-title":"Brain J Neurol"},{"issue":"9","key":"2025021510464230500_fcaf051-B102","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/mds.23054","article-title":"In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: A DTI study using TBSS","volume":"25","author":"Knake","year":"2010","journal-title":"Mov Disord"},{"issue":"1","key":"2025021510464230500_fcaf051-B103","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuroimage.2003.08.028","article-title":"Differentiation of idiopathic Parkinson\u2019s disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging","volume":"21","author":"Eckert","year":"2004","journal-title":"Neuroimage"},{"issue":"10","key":"2025021510464230500_fcaf051-B104","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/brain\/awl166","article-title":"Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson\u2019s disease and progressive supranuclear palsy","volume":"129","author":"Nicoletti","year":"2006","journal-title":"Brain"},{"key":"2025021510464230500_fcaf051-B105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.parkreldis.2016.07.007","article-title":"Cognitive impairment in progressive supranuclear palsy-richardson\u2019s syndrome is related to white matter damage","volume":"31","author":"Caso","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"2025021510464230500_fcaf051-B106","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jmri.22229","article-title":"Microstructural changes in patients with progressive supranuclear palsy: A diffusion tensor imaging study","volume":"32","author":"Wang","year":"2010","journal-title":"J Magn Reson Imaging"},{"key":"2025021510464230500_fcaf051-B107","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2377-12-163","article-title":"Signal alterations of the basal ganglia in the differential diagnosis of Parkinson\u2019s disease: A retrospective case-controlled MRI data bank analysis","volume":"12","author":"Jesse","year":"2012","journal-title":"BMC Neurol"},{"issue":"2","key":"2025021510464230500_fcaf051-B108","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1212\/WNL.0b013e318223c79d","article-title":"Postural imbalance and falls in PSP correlate with functional pathology of the thalamus","volume":"77","author":"Zwergal","year":"2011","journal-title":"Neurology"},{"issue":"12","key":"2025021510464230500_fcaf051-B109","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1212\/01.wnl.0000249307.59950.f8","article-title":"Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI","volume":"67","author":"Blain","year":"2006","journal-title":"Neurology"},{"issue":"11","key":"2025021510464230500_fcaf051-B110","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/mds.28217","article-title":"Multicenter validation of metabolic abnormalities related to PSP according to the MDS-PSP criteria","volume":"35","author":"Marti-Andres","year":"2020","journal-title":"Mov Disord"},{"issue":"4","key":"2025021510464230500_fcaf051-B111","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/mds.21237","article-title":"Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes","volume":"22","author":"Herting","year":"2007","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"2","key":"2025021510464230500_fcaf051-B112","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02251475","article-title":"Positron emission tomography in degenerative disorders of the dopaminergic system","volume":"4","author":"Karbe","year":"1992","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"2","key":"2025021510464230500_fcaf051-B113","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.parkreldis.2013.10.002","article-title":"Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy","volume":"20","author":"Reginold","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"2025021510464230500_fcaf051-B114","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1038\/s41598-019-42565-4","article-title":"Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism","volume":"9","author":"Sjostrom","year":"2019","journal-title":"Sci Rep"},{"key":"2025021510464230500_fcaf051-B115","doi-asserted-by":"crossref","first-page":"909552","DOI":"10.3389\/fnagi.2022.909552","article-title":"Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders","volume":"14","author":"Zhang","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"2025021510464230500_fcaf051-B116","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/ene.15447","article-title":"Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms","volume":"29","author":"Mazzucchi","year":"2022","journal-title":"Eur J Neurol"},{"issue":"1","key":"2025021510464230500_fcaf051-B117","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1038\/s41598-021-82469-w","article-title":"Iron accumulation in the oculomotor nerve of the progressive supranuclear palsy brain","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"key":"2025021510464230500_fcaf051-B118","doi-asserted-by":"crossref","first-page":"116443","DOI":"10.1016\/j.jns.2019.116443","article-title":"Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson\u2019s disease","volume":"406","author":"Azuma","year":"2019","journal-title":"J Neurol Sci"},{"key":"2025021510464230500_fcaf051-B119","doi-asserted-by":"crossref","first-page":"101999","DOI":"10.1016\/j.nicl.2019.101999","article-title":"Quantitative susceptibility mapping in atypical parkinsonisms","volume":"24","author":"Mazzucchi","year":"2019","journal-title":"Neuroimage Clin"},{"key":"2025021510464230500_fcaf051-B120","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2017.09.020","article-title":"Brain regional iron contents in progressive supranuclear palsy","volume":"45","author":"Lee","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"2025021510464230500_fcaf051-B121","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00234-010-0677-6","article-title":"Utility of susceptibility-weighted MRI in differentiating Parkinson\u2019s disease and atypical parkinsonism","volume":"52","author":"Gupta","year":"2010","journal-title":"Neuroradiology"},{"key":"2025021510464230500_fcaf051-B122","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2017.12.021","article-title":"MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism","volume":"48","author":"Sugiyama","year":"2018","journal-title":"Park Relat Disord"},{"issue":"8","key":"2025021510464230500_fcaf051-B123","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/mds.26171","article-title":"Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative parkinsonism","volume":"30","author":"Reiter","year":"2015","journal-title":"Mov Disord"},{"issue":"1","key":"2025021510464230500_fcaf051-B124","first-page":"16","article-title":"Volume of interest analysis of spatially normalized PRESTO imaging to differentiate between Parkinson disease and atypical parkinsonian syndrome","volume":"16","author":"Sakurai","year":"2017","journal-title":"Magn Reson Med Sci MRMS Off J Jpn Soc Magn Reson Med"},{"issue":"6","key":"2025021510464230500_fcaf051-B125","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/mds.28988","article-title":"Regional selectivity of neuromelanin changes in the substantia Nigra in atypical parkinsonism","volume":"37","author":"Chougar","year":"2022","journal-title":"Mov Disord"},{"issue":"3","key":"2025021510464230500_fcaf051-B126","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.29309","article-title":"Neuromelanin-Sensitive magnetic resonance imaging changes in the locus coeruleus\/subcoeruleus complex in patients with typical and atypical parkinsonism","volume":"38","author":"Nobileau","year":"2023","journal-title":"Mov Disord"},{"issue":"8","key":"2025021510464230500_fcaf051-B127","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/mds.29072","article-title":"Locus coeruleus integrity from 7 T MRI relates to apathy and cognition in parkinsonian disorders","volume":"37","author":"Ye","year":"2022","journal-title":"Mov Disord"},{"issue":"7","key":"2025021510464230500_fcaf051-B128","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.parkreldis.2014.04.005","article-title":"Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging","volume":"20","author":"Ohtsuka","year":"2014","journal-title":"Park Relat Disord"},{"issue":"8","key":"2025021510464230500_fcaf051-B129","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1007\/s00330-017-5269-y","article-title":"Progressive supranuclear palsy and idiopathic Parkinson\u2019s disease are associated with local reduction of in vivo brain viscoelasticity","volume":"28","author":"Lipp","year":"2018","journal-title":"Eur Radiol"},{"issue":"3","key":"2025021510464230500_fcaf051-B130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.410240308","article-title":"Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography","volume":"24","author":"Foster","year":"1988","journal-title":"Ann Neurol"},{"issue":"5","key":"2025021510464230500_fcaf051-B131","doi-asserted-by":"crossref","first-page":"880","DOI":"10.4103\/aian.aian_642_21","article-title":"18F-FDG PET\/CT and 99mTc-TRODAT scan findings in the variants of progressive supranuclear palsy and correlation with clinical findings","volume":"25","author":"Seniaray","year":"2022","journal-title":"Ann Indian Acad Neurol"},{"key":"2025021510464230500_fcaf051-B132","doi-asserted-by":"crossref","first-page":"102408","DOI":"10.1016\/j.nicl.2020.102408","article-title":"Gait initiation in progressive supranuclear palsy: Brain metabolic correlates","volume":"28","author":"Palmisano","year":"2020","journal-title":"NeuroImage Clin"},{"issue":"7","key":"2025021510464230500_fcaf051-B133","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1002\/hbm.24044","article-title":"Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts","volume":"39","author":"Ge","year":"2018","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"2025021510464230500_fcaf051-B134","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.parkreldis.2013.10.023","article-title":"The pimple sign of progressive supranuclear palsy syndrome","volume":"20","author":"Botha","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"2025021510464230500_fcaf051-B135","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1212\/WNL.0b013e318281cc43","article-title":"Functional disturbance of the locomotor network in progressive supranuclear palsy","volume":"80","author":"Zwergal","year":"2013","journal-title":"Neurology"},{"issue":"14","key":"2025021510464230500_fcaf051-B136","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/mds.23291","article-title":"Typical cerebral metabolic patterns in neurodegenerative brain diseases","volume":"25","author":"Teune","year":"2010","journal-title":"Mov Disord"},{"issue":"2","key":"2025021510464230500_fcaf051-B137","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.22347","article-title":"Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses","volume":"24","author":"Park","year":"2009","journal-title":"Mov Disord"},{"issue":"5","key":"2025021510464230500_fcaf051-B138","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mds.21933","article-title":"Abnormal metabolic networks in atypical parkinsonism","volume":"23","author":"Eckert","year":"2008","journal-title":"Mov Disord"},{"issue":"8","key":"2025021510464230500_fcaf051-B139","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/mds.20493","article-title":"Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson\u2019s disease","volume":"20","author":"Klein","year":"2005","journal-title":"Mov Disord"},{"issue":"1-2","key":"2025021510464230500_fcaf051-B140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neulet.2005.03.057","article-title":"Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis","volume":"383","author":"Juh","year":"2005","journal-title":"Neurosci Lett"},{"issue":"3","key":"2025021510464230500_fcaf051-B141","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0720-048X(03)00214-6","article-title":"Different metabolic patterns analysis of parkinsonism on the 18F-FDG PET","volume":"51","author":"Juh","year":"2004","journal-title":"Eur J Radiol"},{"issue":"2","key":"2025021510464230500_fcaf051-B142","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/nimg.1999.0463","article-title":"Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia","volume":"10","author":"Garraux","year":"1999","journal-title":"NeuroImage"},{"issue":"5","key":"2025021510464230500_fcaf051-B143","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/1531-8257(200009)15:5<894::AID-MDS1021>3.0.CO;2-S","article-title":"Voxel-based distribution of metabolic impairment in corticobasal degeneration","volume":"15","author":"Treseder","year":"2000","journal-title":"Mov Disord"},{"issue":"4","key":"2025021510464230500_fcaf051-B144","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/RLU.0000000000002949","article-title":"Tau imaging in the 4-repeat-tauopathies progressive supranuclear palsy and corticobasal syndrome: A 11C-pyridinyl-butadienyl-benzothiazole 3 PET pilot study","volume":"45","author":"Schroter","year":"2020","journal-title":"Clin Nucl Med"},{"issue":"Suppl 1","key":"2025021510464230500_fcaf051-B145","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S1353-8020(11)70020-7","article-title":"18F-FDG PET study on the idiopathic Parkinson\u2019s disease from several parkinsonian-plus syndromes","volume":"18","author":"Zhao","year":"2012","journal-title":"Park Relat Disord"},{"issue":"10","key":"2025021510464230500_fcaf051-B146","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.28672","article-title":"Clinical utility of 18F-APN-1607 tau PET imaging in patients with progressive supranuclear palsy","volume":"36","author":"Li","year":"2021","journal-title":"Mov Disord"},{"issue":"5","key":"2025021510464230500_fcaf051-B147","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ana.25893","article-title":"Sensitivity-Specificity of tau and amyloid \u03b2 positron emission tomography in frontotemporal lobar degeneration","volume":"88","author":"Ghirelli","year":"2020","journal-title":"Ann Neurol"},{"key":"2025021510464230500_fcaf051-B148","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fnagi.2019.00249","article-title":"PET imaging of astrogliosis and tau facilitates diagnosis of parkinsonian syndromes","volume":"11","author":"Schonecker","year":"2019","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"2025021510464230500_fcaf051-B149","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ana.25060","article-title":"18F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study","volume":"82","author":"Schonhaut","year":"2017","journal-title":"Ann Neurol"},{"issue":"5","key":"2025021510464230500_fcaf051-B150","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/mds.27643","article-title":"In vivo binding of a tau imaging probe, [11C]PBB3, in patients with progressive supranuclear palsy","volume":"34","author":"Endo","year":"2019","journal-title":"Mov Disord"},{"issue":"1","key":"2025021510464230500_fcaf051-B151","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/mds.26834","article-title":"[18f]AV-1451 tau positron emission tomography in progressive supranuclear palsy","volume":"32","author":"Whitwell","year":"2017","journal-title":"Mov Disord"},{"issue":"1","key":"2025021510464230500_fcaf051-B152","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mds.27546","article-title":"MRI outperforms [18F]AV-1451 PET as a longitudinal biomarker in progressive supranuclear palsy","volume":"34","author":"Whitwell","year":"2019","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"JAN","key":"2025021510464230500_fcaf051-B153","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fnagi.2017.00440","article-title":"[18f]-THK5351 PET correlates with topology and symptom severity in progressive supranuclear palsy","volume":"9","author":"Brendel","year":"2018","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"2025021510464230500_fcaf051-B154","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/mds.26844","article-title":"Subcortical 18F-AV-1451 binding patterns in progressive supranuclear palsy","volume":"32","author":"Cho","year":"2017","journal-title":"Mov Disord"},{"issue":"3","key":"2025021510464230500_fcaf051-B155","first-page":"781","article-title":"18F-AV-1451 positron emission tomography in Alzheimer\u2019s disease and progressive supranuclear palsy","volume":"140","author":"Passamonti","year":"2017","journal-title":"Brain"},{"issue":"1","key":"2025021510464230500_fcaf051-B156","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JAD-130032","article-title":"PET imaging of neuropathology in tauopathies: Progressive supranuclear palsy","volume":"36","author":"Kepe","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"2025021510464230500_fcaf051-B157","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/jamaneurol.2020.2526","article-title":"Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy","volume":"77","author":"Brendel","year":"2020","journal-title":"JAMA Neurol"},{"key":"2025021510464230500_fcaf051-B158","doi-asserted-by":"crossref","first-page":"105226","DOI":"10.1016\/j.parkreldis.2022.11.018","article-title":"Performance of [18F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy","volume":"106","author":"Oliveira Hauer","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"2025021510464230500_fcaf051-B159","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/mds.22533","article-title":"Nigrostriatal upregulation of 5-HT2A receptors correlates with motor dysfunction in progressive supranuclear palsy","volume":"24","author":"Stamelou","year":"2009","journal-title":"Mov Disord"},{"issue":"22","key":"2025021510464230500_fcaf051-B160","doi-asserted-by":"crossref","first-page":"e1989","DOI":"10.1212\/WNL.0000000000005610","article-title":"PK11195 binding in Alzheimer disease and progressive supranuclear palsy","volume":"90","author":"Passamonti","year":"2018","journal-title":"Neurology"},{"issue":"12","key":"2025021510464230500_fcaf051-B161","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s00702-022-02547-9","article-title":"Differential cholinergic systems\u2019 changes in progressive supranuclear palsy versus Parkinson\u2019s disease: An exploratory analysis","volume":"129","author":"Kanel","year":"2022","journal-title":"J Neural Transm"},{"issue":"18","key":"2025021510464230500_fcaf051-B162","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1212\/WNL.0b013e3181dc1a55","article-title":"Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes","volume":"74","author":"Gilman","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"2025021510464230500_fcaf051-B163","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/mds.20668","article-title":"In vivo imaging of microglial activation with [11C]-PK11195 PET progressive supranuclear palsy","volume":"21","author":"Gerhard","year":"2006","journal-title":"Mov Disord"},{"issue":"2","key":"2025021510464230500_fcaf051-B164","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00429-017-1507-y","article-title":"[18f]AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP","volume":"223","author":"Coakeley","year":"2018","journal-title":"Brain Struct Funct"},{"issue":"10","key":"2025021510464230500_fcaf051-B165","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/mds.28188","article-title":"Synaptic loss in primary tauopathies revealed by [11C]UCB-J positron emission tomography","volume":"35","author":"Holland","year":"2020","journal-title":"Mov Disord"},{"issue":"7","key":"2025021510464230500_fcaf051-B166","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-008-0030-y","article-title":"Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson\u2019s disease, PSP and MSA","volume":"115","author":"Bartels","year":"2008","journal-title":"J Neural Transm"},{"key":"2025021510464230500_fcaf051-B167","doi-asserted-by":"crossref","first-page":"105383","DOI":"10.1016\/j.clineuro.2019.105383","article-title":"Midbrain area for differentiating Parkinson\u2019s disease from progressive supranuclear palsy","volume":"183","author":"Ghourchian","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"issue":"8","key":"2025021510464230500_fcaf051-B168","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.parkreldis.2013.04.010","article-title":"Mesencephalic area measured by transcranial sonography in the differential diagnosis of parkinsonism","volume":"19","author":"Sastre-Bataller","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"2025021510464230500_fcaf051-B169","first-page":"446","article-title":"Evaluation of the brainstem with high-resolution CT in cerebellar atrophic processes","volume":"4","author":"Abe","year":"1983","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"2025021510464230500_fcaf051-B170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1212\/WNL.60.1.74","article-title":"Brain parenchyma sonography discriminates Parkinson\u2019s disease and atypical parkinsonian syndromes","volume":"60","author":"Walter","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"2025021510464230500_fcaf051-B171","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00702-014-1310-3","article-title":"Basal ganglia echogenicity in tauopathies","volume":"122","author":"Sadowski","year":"2015","journal-title":"J Neural Transm Vienna"},{"issue":"3","key":"2025021510464230500_fcaf051-B172","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1212\/01.WNL.0000133006.17909.32","article-title":"Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy","volume":"63","author":"Walter","year":"2004","journal-title":"Neurology"},{"key":"2025021510464230500_fcaf051-B173","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.09.032","article-title":"Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study","volume":"68","author":"Alonso-Canovas","year":"2019","journal-title":"Park Relat Disord"},{"issue":"7","key":"2025021510464230500_fcaf051-B174","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00006231-200107000-00007","article-title":"Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET","volume":"22","author":"Zhang","year":"2001","journal-title":"Nucl Med Commun"},{"issue":"30","key":"2025021510464230500_fcaf051-B175","doi-asserted-by":"crossref","first-page":"e16603","DOI":"10.1097\/MD.0000000000016603","article-title":"Thalamic and cerebellar hypoperfusion in single photon emission computed tomography may differentiate multiple system atrophy and progressive supranuclear palsy","volume":"98","author":"Alster","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"2025021510464230500_fcaf051-B176","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archneur.63.8.1154","article-title":"Topography of dopamine transporter availability in progressive supranuclear palsy: A voxelwise [123I]beta-CIT SPECT analysis","volume":"63","author":"Seppi","year":"2006","journal-title":"Arch Neurol"},{"issue":"12","key":"2025021510464230500_fcaf051-B177","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/mds.23179","article-title":"Midbrain SERT in degenerative parkinsonisms: A 123I-FP-CIT SPECT study","volume":"25","author":"Roselli","year":"2010","journal-title":"Mov Disord"},{"issue":"10","key":"2025021510464230500_fcaf051-B178","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.3390\/jcm11102701","article-title":"Is MRPI 2.0 more useful than MRPI and M\/P ratio in differential diagnosis of PSP-P with other atypical parkinsonisms?","volume":"11","author":"Madetko","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"2025021510464230500_fcaf051-B179","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/mds.28901","article-title":"Brainstem biomarkers of clinical variant and pathology in progressive supranuclear palsy","volume":"37","author":"Grijalva","year":"2022","journal-title":"Mov Disord"},{"issue":"1","key":"2025021510464230500_fcaf051-B180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jnnp-2019-321354","article-title":"Midbrain MRI assessments in progressive supranuclear palsy subtypes","volume":"91","author":"Picillo","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025021510464230500_fcaf051-B181","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.nicl.2017.09.008","article-title":"Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy","volume":"16","author":"Brown","year":"2017","journal-title":"NeuroImage Clin"},{"key":"2025021510464230500_fcaf051-B182","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2017.05.005","article-title":"Usefulness of the superior cerebellar peduncle for differential diagnosis of progressive supranuclear palsy: A meta-analysis","volume":"378","author":"Sako","year":"2017","journal-title":"J Neurol Sci"},{"key":"2025021510464230500_fcaf051-B183","doi-asserted-by":"crossref","first-page":"103030","DOI":"10.1016\/j.nicl.2022.103030","article-title":"Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant","volume":"35","author":"Gatto","year":"2022","journal-title":"NeuroImage Clin"},{"issue":"9","key":"2025021510464230500_fcaf051-B184","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1007\/s00415-020-10360-1","article-title":"Diffusion tensor imaging analysis in three progressive supranuclear palsy variants","volume":"268","author":"Whitwell","year":"2021","journal-title":"J Neurol"},{"issue":"9","key":"2025021510464230500_fcaf051-B185","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/brain\/awaa216","article-title":"Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson\u2019s disease","volume":"143","author":"Biondetti","year":"2020","journal-title":"Brain"},{"issue":"7","key":"2025021510464230500_fcaf051-B186","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/mds.28531","article-title":"Longitudinal changes in neuromelanin MRI signal in Parkinson\u2019s disease: A progression marker","volume":"36","author":"Gaurav","year":"2021","journal-title":"Mov Disord"},{"issue":"1","key":"2025021510464230500_fcaf051-B187","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40478-020-0886-0","article-title":"Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity","volume":"8","author":"Kaalund","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"2025021510464230500_fcaf051-B188","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Ann Neurol"},{"issue":"3","key":"2025021510464230500_fcaf051-B189","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000530075","article-title":"Correlation between the regional brain volume and glymphatic system activity in progressive supranuclear palsy","volume":"52","author":"Ota","year":"2023","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2025021510464230500_fcaf051-B190","doi-asserted-by":"crossref","first-page":"923193","DOI":"10.3389\/fnagi.2022.923193","article-title":"Enlarged perivascular spaces and white matter hyperintensities in patients with frontotemporal lobar degeneration syndromes","volume":"14","author":"Wang","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"1-2","key":"2025021510464230500_fcaf051-B191","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jns.2015.07.026","article-title":"Differentiating progressive supranuclear palsy from Parkinson\u2019s disease by MRI-based dynamic cerebrospinal fluid flow","volume":"357","author":"Fukui","year":"2015","journal-title":"J Neurol Sci"},{"issue":"6","key":"2025021510464230500_fcaf051-B192","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/mds.22981","article-title":"Substantia nigra echogenicity in progressive supranuclear palsy","volume":"25","author":"Ebentheuer","year":"2010","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"2025021510464230500_fcaf051-B193","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejmp.2022.04.016","article-title":"Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy","volume":"98","author":"Tomse","year":"2022","journal-title":"Phys Med"},{"issue":"1","key":"2025021510464230500_fcaf051-B194","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.24844","article-title":"Pathological correlations of [F-18]-AV-1451 imaging in non-Alzheimer tauopathies","volume":"81","author":"Marqui\u00e9","year":"2017","journal-title":"Ann Neurol"},{"issue":"11","key":"2025021510464230500_fcaf051-B195","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jalz.2016.01.003","article-title":"Characterization of tau positron emission tomography tracer [(18)F]AV-1451 binding to postmortem tissue in Alzheimer\u2019s disease, primary tauopathies, and other dementias","volume":"12","author":"Sander","year":"2016","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"issue":"Pt A","key":"2025021510464230500_fcaf051-B196","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuroimage.2015.09.014","article-title":"A probabilistic atlas of the cerebellar white matter","volume":"124","author":"van Baarsen","year":"2016","journal-title":"NeuroImage"},{"issue":"5","key":"2025021510464230500_fcaf051-B197","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.3174\/ajnr.A0991","article-title":"The human central nervous system, 4th ed","volume":"29","author":"Nieuwenhuys","year":"2008","journal-title":"Am J Neuroradiol"},{"issue":"7","key":"2025021510464230500_fcaf051-B198","doi-asserted-by":"crossref","first-page":"e0133402","DOI":"10.1371\/journal.pone.0133402","article-title":"Surface-based display of volume-averaged cerebellar imaging data","volume":"10","author":"Diedrichsen","year":"2015","journal-title":"PLoS One"},{"key":"2025021510464230500_fcaf051-B199","doi-asserted-by":"crossref","first-page":"103443","DOI":"10.1016\/j.nicl.2023.103443","article-title":"Brain dysfunction in gait disorders of Caribbean atypical parkinsonism and progressive supranuclear palsy patients: A comparative study","volume":"38","author":"Welter","year":"2023","journal-title":"NeuroImage Clin"},{"issue":"12","key":"2025021510464230500_fcaf051-B200","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.neurobiolaging.2012.02.002","article-title":"Diffusion tensor MRI contributes to differentiate richardson\u2019s syndrome from PSP-parkinsonism","volume":"33","author":"Agosta","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"6","key":"2025021510464230500_fcaf051-B201","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneurol.2011.107","article-title":"Clinical correlates of white matter tract degeneration in progressive supranuclear palsy","volume":"68","author":"Whitwell","year":"2011","journal-title":"Arch Neurol"},{"key":"2025021510464230500_fcaf051-B202","doi-asserted-by":"crossref","first-page":"101899","DOI":"10.1016\/j.nicl.2019.101899","article-title":"Disrupted structural connectivity of fronto-deep gray matter pathways in progressive supranuclear palsy","volume":"23","author":"Abos","year":"2019","journal-title":"NeuroImage Clin"},{"issue":"1","key":"2025021510464230500_fcaf051-B203","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/ene.13185","article-title":"Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy","volume":"24","author":"Lee","year":"2017","journal-title":"Eur J Neurol"},{"issue":"3","key":"2025021510464230500_fcaf051-B204","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3174\/ajnr.A5048","article-title":"A fully automated, atlas-based approach for superior cerebellar peduncle evaluation in progressive supranuclear palsy phenotypes","volume":"38","author":"Nicoletti","year":"2017","journal-title":"Am J Neuroradiol"},{"issue":"9","key":"2025021510464230500_fcaf051-B205","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.26294","article-title":"Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson\u2019s disease","volume":"30","author":"Burciu","year":"2015","journal-title":"Mov Disord"},{"issue":"4","key":"2025021510464230500_fcaf051-B206","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1212\/01.WNL.0000151854.85743.C7","article-title":"Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy","volume":"64","author":"Paviour","year":"2005","journal-title":"Neurology"},{"key":"2025021510464230500_fcaf051-B207","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.parkreldis.2017.03.001","article-title":"White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study","volume":"39","author":"Zanigni","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"2025021510464230500_fcaf051-B208","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1148\/radiol.2019190406","article-title":"Diffusion tensor MRI to distinguish progressive supranuclear palsy from a-synucleinopathies","volume":"293","author":"Spotorno","year":"2019","journal-title":"Radiology"},{"issue":"2","key":"2025021510464230500_fcaf051-B209","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.parkreldis.2013.10.007","article-title":"Potential of a new MRI for visualizing cerebellar involvement in progressive supranuclear palsy","volume":"20","author":"Hara","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"2025021510464230500_fcaf051-B210","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.neurobiolaging.2014.03.028","article-title":"Clinical correlations of microstructural changes in progressive supranuclear palsy","volume":"35","author":"Tessitore","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"11","key":"2025021510464230500_fcaf051-B211","doi-asserted-by":"crossref","first-page":"e112638","DOI":"10.1371\/journal.pone.0112638","article-title":"Diffusion tensor imaging of Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy: A tract-based spatial statistics study","volume":"9","author":"Worker","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"2025021510464230500_fcaf051-B212","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00415-014-7301-3","article-title":"Clinical, cognitive, and behavioural correlates of white matter damage in progressive supranuclear palsy","volume":"261","author":"Agosta","year":"2014","journal-title":"J Neurol"},{"issue":"7","key":"2025021510464230500_fcaf051-B213","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/mds.24990","article-title":"Primary lateral sclerosis as progressive supranuclear palsy: Diagnosis by diffusion tensor imaging","volume":"27","author":"Coon","year":"2012","journal-title":"Mov Disord"},{"issue":"9","key":"2025021510464230500_fcaf051-B214","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/mds.23739","article-title":"Diffusion tensor magnetic resonance imaging tractography in progressive supranuclear palsy","volume":"26","author":"Canu","year":"2011","journal-title":"Mov Disord"},{"issue":"8","key":"2025021510464230500_fcaf051-B215","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.parkreldis.2011.05.013","article-title":"Disrupted thalamocortical connectivity in PSP: A resting-state fMRI, DTI, and VBM study","volume":"17","author":"Whitwell","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"16","key":"2025021510464230500_fcaf051-B216","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/mds.22279","article-title":"Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson\u2019s disease","volume":"23","author":"Nicoletti","year":"2008","journal-title":"Mov Disord"},{"issue":"10","key":"2025021510464230500_fcaf051-B217","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/brain\/awn195","article-title":"Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson\u2019s disease","volume":"131","author":"Rizzo","year":"2008","journal-title":"Brain"},{"issue":"2","key":"2025021510464230500_fcaf051-B218","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00415-019-09566-9","article-title":"18F-AV1451 PET imaging and multimodal MRI changes in progressive supranuclear palsy","volume":"267","author":"Nicastro","year":"2020","journal-title":"J Neurol"},{"issue":"6","key":"2025021510464230500_fcaf051-B219","doi-asserted-by":"crossref","first-page":"e66022","DOI":"10.1371\/journal.pone.0066022","article-title":"Assessment of global and regional diffusion changes along white matter tracts in parkinsonian disorders by MR tractography","volume":"8","author":"Surova","year":"2013","journal-title":"PLoS One"},{"issue":"14","key":"2025021510464230500_fcaf051-B220","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/mds.23915","article-title":"Brain perfusion differences in parkinsonian disorders","volume":"26","author":"Kimura","year":"2011","journal-title":"Mov Disord"},{"issue":"4","key":"2025021510464230500_fcaf051-B221","first-page":"681","article-title":"Diagnostic potential of multimodal MRI markers in atypical parkinsonian disorders","volume":"9","author":"Seki","year":"2019","journal-title":"J Park Dis"},{"issue":"14","key":"2025021510464230500_fcaf051-B222","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/mds.23351","article-title":"Diagnostic accuracy of the magnetic resonance parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson\u2019s disease and the Parkinson variant of multiple system atrophy: Diagnostic accuracy of the MRPI and the m\/p-ratio","volume":"25","author":"Hussl","year":"2010","journal-title":"Mov Disord"},{"issue":"5","key":"2025021510464230500_fcaf051-B223","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/mds.26921","article-title":"Manual MRI morphometry in parkinsonian syndromes","volume":"32","author":"Moller","year":"2017","journal-title":"Mov Disord"},{"issue":"4","key":"2025021510464230500_fcaf051-B224","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10072-016-2489-x","article-title":"Magnetic resonance parkinsonism index in progressive supranuclear palsy and vascular parkinsonism","volume":"37","author":"Mostile","year":"2016","journal-title":"Neurol Sci"},{"key":"2025021510464230500_fcaf051-B225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.parkreldis.2016.04.006","article-title":"Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy","volume":"28","author":"Tsai","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"2025021510464230500_fcaf051-B226","doi-asserted-by":"crossref","first-page":"105483","DOI":"10.1016\/j.parkreldis.2023.105483","article-title":"Characterizing gait and exploring neuro-morphometry in patients with PSP-richardson\u2019s syndrome and vascular parkinsonism","volume":"113","author":"Chatterjee","year":"2023","journal-title":"Park Relat Disord"},{"issue":"7","key":"2025021510464230500_fcaf051-B227","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1101\/lm.048454.118","article-title":"Fronto-parietal contributions to episodic retrieval-evidence from neurodegenerative disorders","volume":"26","author":"Ramanan","year":"2019","journal-title":"Learn Mem Cold Spring Harb N"},{"key":"2025021510464230500_fcaf051-B228","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.parkreldis.2017.03.008","article-title":"Functional disconnection of thalamic and cerebellar dentate nucleus networks in progressive supranuclear palsy and corticobasal syndrome","volume":"39","author":"Upadhyay","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"2025021510464230500_fcaf051-B229","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.parkreldis.2013.02.005","article-title":"Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy","volume":"19","author":"Giordano","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"46","key":"2025021510464230500_fcaf051-B230","doi-asserted-by":"crossref","first-page":"80941","DOI":"10.18632\/oncotarget.20895","article-title":"Brain gray matter abnormalities in progressive supranuclear palsy revisited","volume":"8","author":"Pan","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"2025021510464230500_fcaf051-B231","doi-asserted-by":"crossref","first-page":"fcaa194","DOI":"10.1093\/braincomms\/fcaa194","article-title":"Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy","volume":"2","author":"Tse","year":"2020","journal-title":"Brain Commun"},{"issue":"8","key":"2025021510464230500_fcaf051-B232","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.parkreldis.2015.05.025","article-title":"The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes","volume":"21","author":"Zanigni","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"2025021510464230500_fcaf051-B233","doi-asserted-by":"crossref","first-page":"116627","DOI":"10.1016\/j.jns.2019.116627","article-title":"Differences in cerebellar perfusion between Parkinson\u2019s disease and multiple system atrophy","volume":"409","author":"Murakami","year":"2020","journal-title":"J Neurol Sci"},{"issue":"2","key":"2025021510464230500_fcaf051-B234","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/diagnostics12020385","article-title":"The strengths and obstacles in the differential diagnosis of progressive supranuclear palsy-parkinsonism predominant (PSP-P) and multiple system atrophy (MSA) using magnetic resonance imaging (MRI) and perfusion single photon emission computed tomography","volume":"12","author":"Alster","year":"2022","journal-title":"Diagnostics"},{"key":"2025021510464230500_fcaf051-B235","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia","volume":"10","author":"Steele","year":"1964","journal-title":"Arch Neurol"},{"key":"2025021510464230500_fcaf051-B236","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jneumeth.2013.11.016","article-title":"Machine learning on brain MRI data for differential diagnosis of Parkinson\u2019s disease and progressive supranuclear palsy","volume":"222","author":"Salvatore","year":"2014","journal-title":"J Neurosci Methods"},{"issue":"7","key":"2025021510464230500_fcaf051-B237","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/ene.12432","article-title":"Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases: A semi-quantitative 7.0 T magnetic resonance imaging study","volume":"21","author":"De Reuck","year":"2014","journal-title":"Eur J Neurol"},{"issue":"6","key":"2025021510464230500_fcaf051-B238","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/jnen\/60.6.647","article-title":"Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration","volume":"60","author":"Ishizawa","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"2025021510464230500_fcaf051-B239","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/diagnostics12123022","article-title":"The use of cerebellar hypoperfusion assessment in the differential diagnosis of multiple system atrophy with parkinsonism and progressive supranuclear palsy-parkinsonism predominant","volume":"12","author":"Madetko-Alster","year":"2022","journal-title":"Diagnostics"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcaf051\/61771204\/fcaf051.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/7\/1\/fcaf051\/61771204\/fcaf051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/7\/1\/fcaf051\/61771204\/fcaf051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T10:48:12Z","timestamp":1739616492000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcaf051\/8002813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":239,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,24]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcaf051","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2024,12,24]]},"article-number":"fcaf051"}}